These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. P2 receptor interaction and signalling cascades in neuroprotection. Miras-Portugal MT; Queipo MJ; Gil-Redondo JC; Ortega F; Gómez-Villafuertes R; Gualix J; Delicado EG; Pérez-Sen R Brain Res Bull; 2019 Sep; 151():74-83. PubMed ID: 30593879 [TBL] [Abstract][Full Text] [Related]
4. CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17. Fumagalli M; Lecca D; Abbracchio MP Neuropharmacology; 2016 May; 104():82-93. PubMed ID: 26453964 [TBL] [Abstract][Full Text] [Related]
10. Differential crosstalk between P2X7 and arachidonic acid in activation of mitogen-activated protein kinases. Barbieri R; Alloisio S; Ferroni S; Nobile M Neurochem Int; 2008 Dec; 53(6-8):255-62. PubMed ID: 18804898 [TBL] [Abstract][Full Text] [Related]
11. Glutamate and ATP signalling in white matter pathology. Matute C J Anat; 2011 Jul; 219(1):53-64. PubMed ID: 21250988 [TBL] [Abstract][Full Text] [Related]
12. Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia. Suzuki T; Hide I; Ido K; Kohsaka S; Inoue K; Nakata Y J Neurosci; 2004 Jan; 24(1):1-7. PubMed ID: 14715932 [TBL] [Abstract][Full Text] [Related]
13. Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages. Hu Y; Fisette PL; Denlinger LC; Guadarrama AG; Sommer JA; Proctor RA; Bertics PJ J Biol Chem; 1998 Oct; 273(42):27170-5. PubMed ID: 9765236 [TBL] [Abstract][Full Text] [Related]
14. Coupling of two pools of P2X7 receptors to distinct intracellular signaling pathways in rat submandibular gland. Garcia-Marcos M; Pérez-Andrés E; Tandel S; Fontanils U; Kumps A; Kabré E; Gómez-Muñoz A; Marino A; Dehaye JP; Pochet S J Lipid Res; 2006 Apr; 47(4):705-14. PubMed ID: 16415476 [TBL] [Abstract][Full Text] [Related]
15. Human P2Y Dreisig K; Sund L; Dommer MW; Kristensen NP; Boddum K; Viste R; Fredholm S; Odum N; Jäättelä M; Skov S; Kornum BR Front Immunol; 2018; 9():1159. PubMed ID: 29937766 [TBL] [Abstract][Full Text] [Related]
16. ERK1/2 activation is involved in the neuroprotective action of P2Y13 and P2X7 receptors against glutamate excitotoxicity in cerebellar granule neurons. Ortega F; Pérez-Sen R; Delicado EG; Teresa Miras-Portugal M Neuropharmacology; 2011 Dec; 61(8):1210-21. PubMed ID: 21798274 [TBL] [Abstract][Full Text] [Related]
18. ATP released by LPS increases nitric oxide production in raw 264.7 macrophage cell line via P2Z/P2X7 receptors. Sperlágh B; Haskó G; Németh Z; Vizi ES Neurochem Int; 1998 Sep; 33(3):209-15. PubMed ID: 9759915 [TBL] [Abstract][Full Text] [Related]
19. Large pore formation uniquely associated with P2X7 purinergic receptor channels. Focus on "Are second messengers crucial for opening the pore associated with P2X7 receptor?". Liang L; Schwiebert EM Am J Physiol Cell Physiol; 2005 Feb; 288(2):C240-2. PubMed ID: 15643049 [No Abstract] [Full Text] [Related]
20. Adenylate cyclase 5 coordinates the action of ADP, P2Y1, P2Y13 and ATP-gated P2X7 receptors on axonal elongation. del Puerto A; Díaz-Hernández JI; Tapia M; Gomez-Villafuertes R; Benitez MJ; Zhang J; Miras-Portugal MT; Wandosell F; Díaz-Hernández M; Garrido JJ J Cell Sci; 2012 Jan; 125(Pt 1):176-88. PubMed ID: 22250198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]